Zacks
Novartis Strikes $3B Oncology Deal for Breast Cancer Asset
📈
AI Sentiment
Highly Positive
8/10
- Home
- LQDA
LQDA
Liquidia Corporation
as of 03-24-2026 3:37pm EST
$35.37
$0.15
-0.42%
Liquidia Corp is a United States-based biopharmaceutical company focused on the development, manufacturing, and commercialization of products that address unmet patient needs, with the current focus directed towards the treatment of pulmonary hypertension (PH) and pulmonary hypertension associated with interstitial lung disease. It conducts research, development, and manufacturing of novel products by applying its proprietary PRINT technology, a particle engineering platform, to enable the precise production of uniform drug particles. Its product includes YUTREPIA (treprostinil) inhalation powder, for the treatment of pulmonary arterial hypertension. The company also generates revenue from the sale of Treprostinil Injection through an agreement between its subsidiary and the manufacturer.
| Founded: | 2004 | Country: | United States |
| Employees: | N/A | City: | MORRISVILLE |
| Market Cap: | 3.1B | IPO Year: | 2020 |
| Target Price: | $40.36 | AVG Volume (30 days): | 1.5M |
| Analyst Decision: | Strong Buy | Number of Analysts: | 11 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -0.80 | EPS Growth: | 51.81 |
| 52 Week Low/High: | $11.26 - $46.67 | Next Earning Date: | 03-05-2026 |
| Revenue: | $158,320,000 | Revenue Growth: | 1031.18% |
| Revenue Growth (this year): | 208.46% | Revenue Growth (next year): | 27.44% |
| P/E Ratio: | -45.44 | Index: | N/A |
| Free Cash Flow: | -40022000.0 | FCF Growth: | N/A |
Stock Insider Trading Activity of Liquidia Corporation (LQDA)
Saggar Rajeev
Sell
Chief Medical Officer
LQDA Mar 13, 2026
Avg Cost/Share
$36.30
Shares
35,365
Total Value
$1,283,834.38
Owned After
174,473
SEC Form 4
SINGH RAMAN
Sell
Director
LQDA Mar 13, 2026
Avg Cost/Share
$36.04
Shares
20,000
Total Value
$720,828.00
Owned After
38,755
SEC Form 4
Krepp Sarah
Sell
Chief Human Resource Officer
LQDA Mar 13, 2026
Avg Cost/Share
$38.00
Shares
16,261
Total Value
$617,918.00
Owned After
148,397
SEC Form 4
Moomaw Scott
Sell
Chief Commercial Officer
LQDA Mar 9, 2026
Avg Cost/Share
$35.32
Shares
80,000
Total Value
$2,825,824.00
Owned After
188,954
SEC Form 4
Moomaw Scott
Sell
Chief Commercial Officer
LQDA Mar 2, 2026
Avg Cost/Share
$30.58
Shares
827
Total Value
$25,289.66
Owned After
188,954
SEC Form 4
Kaseta Michael
Sell
CFO and COO
LQDA Mar 2, 2026
Avg Cost/Share
$30.58
Shares
1,165
Total Value
$35,625.70
Owned After
411,855
SEC Form 4
Adair Jason
Sell
Chief Business Officer
LQDA Mar 2, 2026
Avg Cost/Share
$30.58
Shares
689
Total Value
$21,069.62
Owned After
212,479
SEC Form 4
Schundler Russell
Sell
General Counsel
LQDA Mar 2, 2026
Avg Cost/Share
$30.58
Shares
1,073
Total Value
$32,812.34
Owned After
614,057
SEC Form 4
Krepp Sarah
Sell
Chief Human Resource Officer
LQDA Mar 2, 2026
Avg Cost/Share
$30.58
Shares
276
Total Value
$8,440.08
Owned After
148,397
SEC Form 4
Boyle Dana
Sell
Chief Accounting Officer
LQDA Mar 2, 2026
Avg Cost/Share
$30.58
Shares
445
Total Value
$13,608.10
Owned After
178,840
SEC Form 4
| Insider | Ticker | Relationship | Date | Transaction | Avg Cost | Shares | Total Value | Owned After | SEC Forms |
|---|---|---|---|---|---|---|---|---|---|
| Saggar Rajeev | LQDA | Chief Medical Officer | Mar 13, 2026 | Sell | $36.30 | 35,365 | $1,283,834.38 | 174,473 | |
| SINGH RAMAN | LQDA | Director | Mar 13, 2026 | Sell | $36.04 | 20,000 | $720,828.00 | 38,755 | |
| Krepp Sarah | LQDA | Chief Human Resource Officer | Mar 13, 2026 | Sell | $38.00 | 16,261 | $617,918.00 | 148,397 | |
| Moomaw Scott | LQDA | Chief Commercial Officer | Mar 9, 2026 | Sell | $35.32 | 80,000 | $2,825,824.00 | 188,954 | |
| Moomaw Scott | LQDA | Chief Commercial Officer | Mar 2, 2026 | Sell | $30.58 | 827 | $25,289.66 | 188,954 | |
| Kaseta Michael | LQDA | CFO and COO | Mar 2, 2026 | Sell | $30.58 | 1,165 | $35,625.70 | 411,855 | |
| Adair Jason | LQDA | Chief Business Officer | Mar 2, 2026 | Sell | $30.58 | 689 | $21,069.62 | 212,479 | |
| Schundler Russell | LQDA | General Counsel | Mar 2, 2026 | Sell | $30.58 | 1,073 | $32,812.34 | 614,057 | |
| Krepp Sarah | LQDA | Chief Human Resource Officer | Mar 2, 2026 | Sell | $30.58 | 276 | $8,440.08 | 148,397 | |
| Boyle Dana | LQDA | Chief Accounting Officer | Mar 2, 2026 | Sell | $30.58 | 445 | $13,608.10 | 178,840 |
Earnings Transcripts
SEC 8-K filings with transcript text
2025 Q4 Q4 2025 Earnings
8-K SELL Mar 5, 2026 · 99% conf.
2025
Q4
Q4 2025 Earnings
8-K SELLMar 5, 2026 · 99% conf.
AI Prediction SELL
1D
-1.99%
$34.38
Act: +3.91%
5D
-5.04%
$33.31
20D
+2.73%
$36.03
Price: $35.08 Prob +5D: 0% AUC: 1.000
0001104659-26-023794
false 0001819576
0001819576
2026-03-05 2026-03-05
iso4217:USD
xbrli:shares
iso4217:USD
xbrli:shares
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): March 5, 2026
LIQUIDIA CORPORATION
(Exact name of registrant as specified in its charter)
Delaware 001-39724 85-1710962
(State or other jurisdiction
of incorporation) (Commission
File Number) (IRS Employer
Identification No.)
419 Davis Drive, Suite 100, Morrisville, North Carolina 27560
(Address of principal executive offices) (Zip Code)
Registrant’s telephone number, including area code: (919) 328-4400
(Former name or former address, if changed since last report.)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act:
Title of each class Trading Symbol(s) Name of each exchange on which registered
Common stock
LQDA
The Nasdaq Stock Market LLC
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company ¨
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨
Item 2.02 Results of Operations and Financial Condition.
On March 5, 2026, Liquidia Corporation, a Delaware corporation, issued a press release announcing its financial results for the full year ended December 31, 2025, and also provided a corporate update. A copy of the press release is furnished herewith as Exhibit 99.1.*
Item 9.01 Financial Statements and Exhibits.
(d)
Exhibit
No.
Exhibit
99.1
Press Release of Liquidia Corporation, dated March 5, 2026.
104
Cover Page Interactive Data File (embedded within the Inline XBRL document).
* The information in Item 2.02 of this Form 8-K shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such a filing.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
March 5, 2026 Liquidia Corporation
By: /s/ Michael Kaseta
Name: Michael Kaseta
Title: Chief Financial Officer and Chief Operating Officer
2025 Q3 Q3 2025 Earnings
8-K Nov 3, 2025
2025
Q3
Q3 2025 Earnings
8-KNov 3, 2025
0001104659-25-105199
false 0001819576
0001819576
2025-11-03 2025-11-03
iso4217:USD
xbrli:shares
iso4217:USD
xbrli:shares
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): November 3, 2025
LIQUIDIA CORPORATION
(Exact name of registrant as specified in its charter)
Delaware 001-39724 85-1710962
(State or other jurisdiction
of incorporation) (Commission
File Number) (IRS Employer
Identification No.)
419 Davis Drive, Suite 100, Morrisville, North Carolina 27560
(Address of principal executive offices) (Zip Code)
Registrant’s telephone number, including area code: (919) 328-4400
(Former name or former address, if changed since last report.)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act:
Title of each class Trading Symbol(s) Name of each exchange on which registered
Common stock
LQDA
The Nasdaq Stock Market LLC
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company ¨
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨
Item 2.02 Results of Operations and Financial Condition.
On November 3, 2025, Liquidia Corporation, a Delaware corporation, issued a press release announcing its financial results for the quarter ended September 30, 2025, and also provided a corporate update. A copy of the press release is furnished herewith as Exhibit 99.1.*
Item 9.01 Financial Statements and Exhibits.
(d)
Exhibit
No.
Exhibit
99.1
Press Release of Liquidia Corporation, dated November 3, 2025.
104
Cover Page Interactive Data File (embedded within the Inline XBRL document).
* The information in Item 2.02 of this Form 8-K shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such a filing.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
November 3, 2025 Liquidia Corporation
By: /s/ Michael Kaseta
Name: Michael Kaseta
Title: Chief Financial Officer and Chief Operating Officer
2025 Q2 Q2 2025 Earnings
8-K Aug 12, 2025
2025
Q2
Q2 2025 Earnings
8-KAug 12, 2025
0001104659-25-076412
false 0001819576
0001819576
2025-08-12 2025-08-12
iso4217:USD
xbrli:shares
iso4217:USD
xbrli:shares
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): August 12, 2025
LIQUIDIA CORPORATION
(Exact name of registrant as specified in its charter)
Delaware 001-39724 85-1710962
(State or other jurisdiction
of incorporation) (Commission
File Number) (IRS Employer
Identification No.)
419 Davis Drive, Suite 100, Morrisville, North Carolina 27560
(Address of principal executive offices) (Zip Code)
Registrant’s telephone number, including area code: (919) 328-4400
(Former name or former address, if changed since last report.)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act:
Title of each class Trading Symbol(s) Name of each exchange on which registered
Common stock
LQDA
The Nasdaq Stock Market LLC
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company ¨
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨
Item 2.02 Results of Operations and Financial Condition.
On August 12, 2025, Liquidia Corporation, a Delaware corporation, issued a press release announcing its financial results for the quarter ended June 30, 2025, and also provided a corporate update. A copy of the press release is furnished herewith as Exhibit 99.1.*
Item 9.01 Financial Statements and Exhibits.
(d)
Exhibit
No.
Exhibit
99.1
Press Release of Liquidia Corporation, dated August 12, 2025.
104
Cover Page Interactive Data File (embedded within the Inline XBRL document).
* The information in Item 2.02 of this Form 8-K shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such a filing.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
August 12, 2025 Liquidia Corporation
By: /s/ Michael Kaseta
Name: Michael Kaseta
Title: Chief Financial Officer and Chief Operating Officer
Latest Liquidia Corporation News
LQDA Breaking Stock News: Dive into LQDA Ticker-Specific Updates for Smart Investing
Zacks
Can Liquidia Corporation (LQDA) Run Higher on Rising Earnings Estimates?
📈
AI Sentiment
Highly Positive
10/10
Zacks
Wall Street Analysts See a 35.35% Upside in Liquidia Corporation (LQDA): Can the Stock Really Move This High?
📈
AI Sentiment
Highly Positive
9/10
Simply Wall St.
Why Liquidia (LQDA) Is Down 5.1% After Swing to Profit and $125 Million Shelf Filings
📈
AI Sentiment
Highly Positive
8/10
Compare LQDA vs Leading Stocks
See how LQDA stacks up against similar companies in the market
Head-to-Head Comparisons
Share on Social Networks:
Tools & Resources
Enhance your trading experience with our free tools
Disclaimer
The information presented on this page, "LQDA Liquidia Corporation - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.